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Background: Age-adjusted rates of obesity are reported to be 35.8 % among US adult women and 49 % in some
race/ethnicity, underserved populations. (1). Underserved populations often have less access to weight-loss
intervention options and are at high risk for obesity related problems including anovulation, infertility,
pregnancy-related complications and adverse long-term health outcomes. (2). The purpose of this study was to
evaluate a home exercise plan using a pedometer on weight loss, ovulation induction and pregnancy rates in our
overweight and obese underserved clinic population.
Methods: Twenty one overweight (BMI ≥ 25–29.9) and obese I-II (BMI ≥ 30–39.9) 18–42 years old were recruited.
Participants received an exercise/nutrition questionnaire at the initiation and completion and called weekly for
4 weeks. Ten participants were randomly assigned to the home exercise program (PedGp). PedGp received a
pedometer, daily step-count goal, and were called to increase goal by 50 % weekly. All participants then underwent
clomiphene stair-step ovulation induction. All study participants were referred to the University Wellness Clinic for
diet and exercise counseling.
Results: There were high percentages of women with co-morbidities in both groups including fatty liver, low
vitamin D, hyperlipidemia, hypothyroidism, prediabetes and diabetes.
1. Those completing the 4-week home program increased baseline steps by 21.2 % weekly. Only 3/10 women
reached at least one weekly goal of 50 % increase. Although the goal was rarely met, participants who completed
study had increased number of daily steps.
2. Greater number in PedGp lost weight or stayed the same (5/10 vs. 2/11).
3. Greater number in PedGp spontaneously ovulated (4/10 vs. 1/11) or became pregnant (4/10 vs. 3/11).
(not statistically significant due to small sample size).
Conclusion: There are high percentages of comorbidities in this population. Although the goal was rarely met,
participants who completed study had increased number of daily steps. A greater number in PedGp lost weight or
stayed the same. A greater number in PedGp spontaneously ovulated or became pregnant (not statistically significant
due to small sample size). Importantly, 40 % of women who lost weight became pregnant. This is highly encouraging
and suggests that the development of pedometer interventions may prove a cost effective option. Weight loss
programs for this population hold promise and efficient hospital or community-based programs may prove beneficial.* Correspondence: shoupe@usc.edu
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As obesity rates continue to rise across the US, more pa-
tients seeking fertility services are overweight or obese.
In 2012, 35.8 % of adult US women are categorized as
obese (BMI ≥ 30 kg/m2), and this increases to up to 49 %
in some racial, underserved populations [1]. Within this
setting, many of these patients have polycystic ovarian
syndrome, which contributes to their infertility. Further,
these populations are at high risk for obesity related prob-
lems including infertility, anovulation, pregnancy-related
complications and adverse long-term health outcomes [2].
Unfortunately, there is limited evidence-based data for the
management of these populations in a non-IVF setting.
First line treatment for anovulatory PCOS women
seeking fertility is ovulation induction, historically, via
clomiphene citrate, often with the use of metformin [3].
It is generally believed that achieving ovulation induc-
tion in PCOS patients is more difficult than in non-
PCOS populations. Further, higher BMI values are also
associated with poorer outcomes.
Weight loss serves as the best means of physiologically
inducing ovulation in overweight and obese women with
PCOS [4]. Prior studies have shown the anthropometric
benefits of weight loss in these populations, with regard
to restoring ovulatory cycles and allowing spontaneous
pregnancy [5]. Specifically, with loss of only 5-10 % of
body weight, studies have shown resumption of ovula-
tion within 6 months [6]. However, achieving weight loss
in these studies often involves rigid dietary restrictions
or expensive, time consuming exercise interventions,
less accessible to underserved populations [7]. In con-
trast, the pedometer is an inexpensive, simple tool that
may motivate and monitor exercise, and be used as a
surrogate to reliably and objectively quantify physical
activity [8, 9].
We set out to evaluate the effect of a home exercise
regimen using a pedometer plus nutrition counseling on
weight loss, ovulation induction and pregnancy rates, in
underserved, overweight or obese PCOS women desiring
fertility. It was hypothesized that those in the pedometer
group will have increased rates of ovulation and preg-
nancy as compared to those without the intervention.
Methods
Study subjects and procedures
This study was conducted at Los Angeles County + Uni-
versity of Southern California (LAC +USC) Medical
Center. Per the 2013 California Office of Statewide
Health Planning and Development (OSHPD) census,
Hispanics constitute over 60 % of the population in the
surrounding Medical Service Study Area (MSSA), with
68 % of the population determined to be within 200 % of
the federal poverty. Further, nearly two-thirds of the
hospital’s payer mix includes Medicaid and uninsured orunder-insured populations. Study participants were re-
cruited from the Reproductive Endocrinology (REI)
Clinic who were seeking fertility evaluation and treat-
ment. Those with a diagnosis of PCOS per the NIH criteria
were eligible for enrollment if they were female of repro-
ductive age (18–42 years), anovulatory with a BMI catego-
rized as overweight or obese, and without other known
conditions contributing to infertility, including hyperprolac-
tinemia, hypothyroidism, male factor or uncontrolled insu-
lin resistance. Patients with untreated endometrial
hyperplasia, undiagnosed endometrial bleeding, uncon-
trolled hypertension or diabetes or thyroid dysfunction
were excluded from the study [10]. Diabetes and prediabe-
tes were diagnosed in accordance with the American
Diabetes Association criteria. Patients with hemoglobin
A1c (HbA1c) levels between 5.7 and 6.4 % were considered
to be pre-diabetic [11]. Subjects were further screened to
exclude those with a functional cyst greater than 15 mm,
candidates for intrauterine insemination due to an HIV
positive male partner, or other medical conditions preclud-
ing an advisable pregnancy. Recruitment continued through
a 12-month recruitment period. Written informed consent,
approved by the University of Southern California Health
Science Campus Institutional Review Board, of each partici-
pant was obtained prior to inclusion in the study. Upon de-
termination of eligibility, demographics, baseline lab results,
information regarding each ovulation induction cycle and
prior pregnancy outcomes were abstracted from each par-
ticipant’s medical record.
Study design
In this randomized controlled pilot study, ovulation and
pregnancy rates in overweight and obese PCOS women
receiving a pedometer were compared to those not re-
ceiving pedometers. All study participants were treated
according to the usual established LAC +USC REI clinic
protocols, which includes various blood draws for ana-
lysis. All study participants were referred per protocol to
the Wellness Clinic for dietary and exercise counseling.
All participants received a validated exercise/nutrition
questionnaire to determine their baseline diet and exer-
cise habits. After completion of the questionnaire, par-
ticipants were randomized to either receive a pedometer
or no pedometer, according to an even (pedometer) or
odd (no pedometer) outcome via a random number gen-
erator, and all data was recorded by these assigned
codes. Pedometers were used according to package in-
sert instructions. Those who were assigned to the inter-
vention group also received an exercise diary in which to
record their pedometer reading. All participants were
called each week to discuss their exercise and nutrition
goals. Counseling was the same in each group, except
those in the pedometer group also reviewed their weekly
step count and were given specific goals to increase the
Table 2 Baseline mean ± SD indices and p values in ONLY
participants with ovulation or pregnancy
Ovulation Pregnancy
BMI 31.41 (3.39) 0.048* 0.18
HbA1c 5.90 (1.60) 0.46 0.33
Glucose 106.52 (50.39) 0.54 0.59
TSH 2.45 (0.87) 0.35 0.31
Testosterone 47.62 (17.93) 0.29 0.33
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10,000 steps per day. After 4 weeks, all participants’
weights were recorded at their visit.
Following the intervention period, the current guide-
lines and clinic protocols for stepwise ovulation induc-
tion with clomiphene citrate was followed for all
participants. In the event of pregnancy at any time point,
the patient was referred to OB and their chart was peri-
odically reviewed to ascertain pregnancy outcome.Vit D Deficiency 27.68 (12.28) 0.78 0.57
* Significant at p < 0.05 level compared to non-responders
Statistical analysis
Significance of baseline HbA1c, glucose levels, thyroid
stimulating hormone (TSH), testosterone and Vitamin D
levels were compared in those who ovulated or became
pregnant via independent t-tests. Categorical variables
were compared between groups using Fisher Exact and
Chi-Squared tests.Results
Twenty-one overweight (BMI ≥ 25–29.9) and obese I-
II (BMI ≥ 30–39.9) 18–42 year-old PCOS women
seeking infertility services were recruited and met in-
clusion criteria. Ten were randomly assigned to re-
ceive a pedometer and 11 to the non-intervention
group. Table 1 shows the baseline metabolic markers
of the included participants. No significant differences
were seen (p >0.05) amongst BMI, HbA1c, glucose,
hypothyroid status, testosterone, DHEAS or Vitamin D
levels between the control and pedometer groups. There
was a high percentage of comorbidities in this under-
served population, including low Vitamin D, overt and
subclinical hypothyroidism, non-alcoholic fatty liver,
hyperlipidemia, elevated androgens, hypertension and de-
pression, diabetes and prediabetes.
Data on ovulation and pregnancy rates in participants
relative to baseline characteristics is seen in Table 2. A
significant association was found between BMI and ovu-
lation, (p = 0.048, SD 3.39). There were no significant





BMI≥ 25–29.9 kg/m2 30 % (n = 3) 63.6 % (n = 7)
BMI≥ 30–39.9 kg/m2 70 % (n = 7) 36.4 % (n = 4)
HbA1c≥ 6 % 30 % (n = 3) 18.1 % (n = 2)
Glucose≥ 100 mg/dL 40 % (n = 4) 45.5 % (n = 5)
Hypothyroidism 30 % (n = 3) 36.4 % (n = 4)
Elevated Testosterone (≥49 ng/dL) 20 % (n = 2) 63.6 % (n = 7)
Elevated DHEAS (>320 μg/dL) 20 % (n = 2) 27.3 % (n = 3)
Vitamin D, 25-OH deficiency
(<30 ng/mL)
70 % (n = 7) 63.6 % (n = 7)elevated glucose, TSH, testosterone, or low Vitamin D
and ovulation or pregnancy rates.
A total of 7 patients became pregnant, 4 in the ped-
ometer group and 3 in the control, although this was
not statistically significant. A greater number in pedom-
eter group spontaneously ovulated (4/10 vs. 1/11) and
became pregnant (4/10 vs. 3/11), although this was not
statistically significant due to the small sample size. 40 %
of the patients in the pedometer group completed the 4-
week home program and increased their baseline steps
by 21.2 % weekly. Further, 5 of 10 (50 %) of the partici-
pants in the pedometer group lost weight or stayed the
same, compared to 2 of 11 (18.2 %) of those without a
pedometer [p = 0.5]. The step count goal of a 50 % in-
crease in steps weekly, to a maximum of 10,000 steps
per day was rarely met (in 3 of 10 participants), although
participants who completed the study had an increased
number of daily steps.Discussion
PCOS is often associated with anovulatory cycles, and
therefore infertility. As obesity rates in the US continue
to trend upward, an increasing number of women seek-
ing out infertility services, including those with PCOS,
will fall within an elevated BMI range [1]. While first
line treatment for PCOS women with infertility is ovula-
tion induction with clomiphene citrate, this syndrome is
associated with poorer ovulation induction outcomes
than in those without the condition. Further, obesity is
independently correlated with the interruption of regular
ovulatory cycles, while a 5-10 % weight reduction is
associated with return of ovulatory function [5, 6].
Assisted Reproductive Technologies (ART), including
IVF, remains a viable option, although it is largely
unsubsidized by insurance carriers, necessitating alterna-
tive, more cost-effective fertility options. Such is the case
for the women with PCOS in the LAC + USC REI under-
served clinic population. This study evaluated the effect-
iveness of one such economical option, by randomly
assigning PCOS women to receive a pedometer or not,
to ascertain the efficacy of an at home exercise plan and
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tion and pregnancy rates.
The results of this study are promising, as a greater
number in the pedometer group lost weight or stayed
the same (5/10 vs. 2/11), spontaneously ovulated (4/10
vs. 1/11), or became pregnant (4/10 vs. 3/11) as com-
pared to the control arm. Those who completed the 4-
week exercise regimen had a 21.2 % increase in step
count from baseline, although often without meeting the
50 % increase step count goal. Further, 40 % of women
who lost weight became pregnant, suggesting a similar
study with a larger sample size and increased compli-
ance may find a significant increase in these study end-
points. Since the weekly follow-up phone calls proved to
be a highly time intensive interventional structure, alter-
native protocols may be more feasible in a community
setting. In motivated participants, increasing daily phys-
ical activity, as objectively measured by a pedometer re-
cording daily steps, may result in weight loss and
increased ovulation and pregnancy rates.
Various factors serve as unique hurdles against the ef-
fectiveness of an at-home intervention in underserved
populations. Firstly, there is a high percentage of comor-
bidities in this population. Although patients with
known unregulated comorbidities contributing to infer-
tility were excluded, many of the participants had condi-
tions known to independently affect fertility, such as
thyroid dysfunction. Further, while the use of pedometers
has been proven to be a reliable and objective measurement
of physical activity, and one that may encourage exercise,
social factors may have prevented the pedometer-assigned
participants from achieving their weekly step count goals or
consuming low calorie foods [8, 9]. Per patient reporting,
these include the safety of their neighborhoods, long work
hours and the cost and accessibility to fresh produce,
amongst others. Thus, one must consider the effectiveness
of a pedometer-based intervention in this clinic population,
given their specific obstacles.
This study investigated an area with a current paucity
of evidence-based data, through the use of a low-cost
intervention. Possible limitations of the study include a
small sample size, poor compliance and lack of sufficient
power to identify statistically significant differences in
baseline characteristics and ovulation and pregnancy
rates amongst the pedometer and control groups.
While the limited sample size precludes one from de-
fining the definitive effectiveness of such an intervention,
the use of a pedometer in an at-home exercise regimen
with weekly step-count goals and phone follow-up, may
prove to be a cost-effective intervention for both weight
loss and fertility. Future research may further elucidate
the relationship between pedometer use weight loss,
ovulation and pregnancy rates, in addition to identifying
additional cost-effective options.Authors’ contributions
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